Clinical Trial Update: ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) [NA]

View source ↗

Summary

The ILUMIEN IV: OPTIMAL PCI trial by Abbott Medical Devices has completed and posted results for imaging-guided percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Coronary Stenosis
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease, Coronary Stenosis | NA | Status: COMPLETED | Results posted: 2024-08-01